Warning Letter Wednesday Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Advertising net impression is important to consider
Takeaway -
Sketchy weight loss product attracts attention
Takeaway -
The NAD+ battles continue
Takeaway -
Use caution when making public statements
Takeaway -
Train all social media staff in the nuances of implied claims
Takeaway -
Review clinical study parameters with experts
Takeaway -
Net impression and context matter
Takeaway -
Importance of compliance & testing
Takeaway -
Risky product category + disease claims = warning letter
Takeaway -
Importance of a quality management system
Takeaway -
Ensure 483 responses are complete
Takeaway -
Ensure all data is defensible when making comparisons